Evidence map›Paper›PMID 40329347›Full record

ArticleBiological research2025

Ptprd deficiency promotes tau hyperphosphorylation and impairs cognitive function in aged mice.

Analía Foncea, Nayhara Franchini, Isidora Tobar, Sebastián Thienel, Ignacio N Retamal, Gonzalo I Cancino, Francisca Cornejo

Abstract read
In one paragraph

Article in Biological research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Analía Foncea *Centro de Biología Integrativa, Facultad de Ciencias, Universidad Mayor, Santiago, Chile.
Nayhara Franchini *Centro de Biología Integrativa, Facultad de Ciencias, Universidad Mayor, Santiago, Chile.
Isidora TobarCentro de Biología Integrativa, Facultad de Ciencias, Universidad Mayor, Santiago, Chile.
Sebastián ThienelCentro de Biología Integrativa, Facultad de Ciencias, Universidad Mayor, Santiago, Chile.
Ignacio N RetamalCentro de Oncología de Precisión, Escuela de Medicina, Facultad de Medicina y Ciencias de la Salud, Universidad Mayor, Santiago, Chile.
Gonzalo I CancinoLaboratorio de Neurobiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile. gcancino@uc.cl.
Francisca CornejoCentro de Biología Integrativa, Facultad de Ciencias, Universidad Mayor, Santiago, Chile. francisca.cornejo@umayor.cl.ORCID http://orcid.org/0000-0001-9280-3430

Funding

Agencia Nacional de Investigación y Desarrollo 11220563Agencia Nacional de Investigación y Desarrollo 11220708Agencia Nacional de Investigación y Desarrollo 1210507
6 · The paper itself

Abstract

backgroundTau phosphorylation is a tightly regulated process that ensures proper neuronal function. Indeed, hyperphosphorylation of tau closely contributes to neuronal dysfunction leading to neurodegenerative diseases, including tauopathies, which are characterized by excessive and aberrant tau phosphorylation and cognitive decline. Therefore, it is important to understand how to regulate its phosphorylation. In this regard, the protein tyrosine phosphatase receptor delta (PTPRD) has been genetically implicated in tau pathology in humans, but the mechanisms underlying its role in tau regulation remain unclear. This study investigates the impact of Ptprd deficiency on tau phosphorylation, cognitive function, neuroinflammation, and synaptic markers in aging mice.

resultsMice lacking Ptprd showed increased tau phosphorylation at multiple sites associated with its pathological aggregation. This effect was accompanied by the activation of the tau-related kinase Abl1, particularly in the hippocampus. Behavioral assessments revealed significant impairments in learning and memory, demonstrating the functional impact of these alterations. Moreover, Ptprd knockout mice showed increased microgliosis in both the entorhinal cortex and the hippocampus, suggesting a pro-inflammatory response. Furthermore, the synaptic protein PSD95 was also reduced in the cortex, indicating potential synaptic dysfunction.

conclusionsThe loss of Ptprd leads to increased tau phosphorylation, cognitive impairments, microgliosis, and synaptic alterations in older mice. Our findings also suggest that Ptprd plays a critical role in maintaining tau homeostasis through the Abl1 kinase. This indicates a new potential therapeutic approach for tauopathies, where PTPRD could serve a protective role against tau-related pathologies and may act as a key modulator in disease progression.

Indexed as

AgingCognitionCognitive DysfunctionReceptor-Like Protein Tyrosine Phosphatases, Class 2tau ProteinsAnimalsHippocampusMaleMiceMice, Inbred C57BLMice, KnockoutPhosphorylationTauopathiesReceptor-Like Protein Tyrosine Phosphatases, Class 2tau ProteinsABL1Cognitive impairmentMicrogliosisPTPRDSynaptic dysfunctionTauopathyTau phosphorylation

Identifiers

PMID40329347
PMCPMC12054186

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.